6月24日,浙江横店传出信息:经国家药品食品监督管理局批准,浙江康裕制药有限公司开发研制的年产500 t 麻黄碱系列原料药生产线日前正式投入生产。这是迄今为止我国最大的麻黄碱生产线。据介绍:该公司年产500 t 麻黄碱系列原料药生产线项目被列为国家重点技术改造项目,国家“双高一优”项目和第七批国债专项资金项目。 June 24, Zhejiang Hengdian Outgoing Information: Approved by the State Food and Drug Administration, Zhejiang Kangyu Pharmaceutical Co., Ltd. developed an annual output of 500 t ephedrine series of raw materials drug production line has formally put into production. This is by far the country’s largest ephedrine production line. According to reports: The company with an annual output of 500 t ephedrine series of APIs production line project was listed as the state’s key technological transformation projects, the national “double high one excellent” project and the seventh batch of special treasury bonds funds projects.